|Scott Henry, CFA
Head of Pharmaceuticals Research
|Roth Capital Partners|
Director – Biotechnology
Director of Research
Anavex®Life Sciences Corporation is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Anavex®Life Sciences’ performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Anavex®Life Sciences or its management. Anavex®Life Sciences does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.